Investors are rushing into the relative safe haven of the bond market, causing the yield on the U.S. 10-year Treasury to plummet.Real Estateread more
President Donald Trump on Thursday directed the U.S. intelligence community to "quickly and fully cooperate" with Attorney General William Barr's investigation into the...Politicsread more
The embattled leader is expected to outline a timetable for her successor to be chosen.Europe Politicsread more
Despite a decline in global commercial real estate markets, Asia-Pacific continues to enjoy a record-breaking growth — thanks to China, according to the Global Capital Flows...Real Estateread more
The Wall Street Journal and The New York Times, citing people familiar with the deal, reported that $30 million would go to plaintiffs and $14 million would be used to pay...Entertainmentread more
Assets under management at Swiss private bank Julius Baer rose 12% in the first four months of 2019 to a record 427 billion Swiss francs ($425.34 billion).Earningsread more
Wall Street is becoming convinced that both the White House and Beijing are willing to engage in a protracted trade war that could begin to hit consumers and slow global...Market Insiderread more
The U.S. Commerce Department said its proposed rule would amend the normal countervailing duty process to include new criteria for currency undervaluation.World Economyread more
SpaceX sent 60 satellites into space in a key first mission toward the company's own high-speed internet network.Internetread more
Zilingo founder Ankiti Bose says working as an investment analyst helped her build her near-$1 billion fashion start-up.Ditching the Corporate Liferead more
TransferWise, the money transfer start-up, was valued at $3.5 billion after investors bought $292 million of shares in a secondary sale.Technologyread more
"While the market certainly looked comatose, we're witnessing some tremendous breakouts all over the place, breakouts that typically would be held back by the gravitational pull of profit-taking or higher interest rates or, yes, politics," the "Mad Money" host said.
Strangely enough, Cramer didn't see many of those bearish theories meaningfully weighing on stocks in Monday's session.
Instead, analysts took to the tape to raise their price targets on stocks of companies they thought needed value-related boosts, he said.
But over the past several months, the stock has been "sneaking up, seemingly for no good reason," Cramer noted. That, he said, prompted J.P. Morgan's pharmaceutical industry analyst to issue a very positive note on the drugmaker.
"Its drug analyst came out [Monday] and said that Lilly was one of the 'best position names' in the group," Cramer said. "The note then totally rehashes exactly the same bull argument that could've been done 10 points ago in the $70s, except now it's in the mid-$80s."
The note argued that Eli Lilly has a variety of different assets that could set it apart from other pharmaceuticals. It also said that while the company's diabetes franchise was facing some noteworthy competition, it could be diversified enough to stay afloat.
"Hey, J.P. Morgan, where were you at $76?" the "Mad Money" host quipped.
But Eli Lilly's good fortune was more than just that, Cramer said. He argued that it also symbolized how analysts were viewing this market: as a raging bull where, if you miss the hidden value, you might get left behind.
"Here's the bottom line: there are many reasons why a stock market that you think should go down ... doesn't go down, and most of them have little to do with trade," Cramer said. "You should be thinking positively, not negatively, these days if your stock's had a nice run or even if it hasn't. There are just too many good things that might happen to justify getting too pessimistic."
Disclosure: Cramer's charitable trust owns shares of Eli Lilly and J.P. Morgan.